H.R. 3605 (98th): Drug Price Competition and Patent Term Restoration Act of 1984

Introduced:

Jul 19, 1983
98th Congress, 1983–1984

Status:
Died in a previous Congress

This bill was introduced in a previous session of Congress and was passed by the House on September 6, 1984 but was never passed by the Senate.

Sponsor:

Henry Waxman
Representative for California's 24th congressional district
Democrat

About the bill

Full Title

A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize an abbreviated new drug application under section 505 of that Act for generic new drugs equivalent to approved new drugs.

Read CRS summary >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 1538 (Related)
Patent Law Amendments of 1983

Enacted — Signed by the President
Sep 24, 1984

H.Res. 569 (rule)

Introduced
Last Action: Aug 8, 1984

What is a bill?

The “H.R.” in “H.R. 3605” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
Jul 19, 1983
Reported by Committee
Jun 12, 1984
Passed House
Sep 6, 1984

Details

Cosponsors
15 cosponsors (14D, 1R) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.

Votes
Sep 6, 1984 midnight
unknown 362/0

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: